Kevin M. Farr - CHIEF FINANCIAL OFFICER at Niagen Bioscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
NAGE on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin M. Farr since 4/23/2024

Holdings reported by Kevin M. Farr for Niagen Bioscience, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Options (right to buy) 122K Feb 17, 2022 Direct Common Stock
Restricted Stock Unit 89.2K Aug 12, 2022 Direct Common Stock

Transactions reported by Kevin M. Farr for Niagen Bioscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.